Announcements Trials
Browse Landscape

Phase

Phase 2 6

Status

Terminated 3Completed 3

Sponsor Class

OTHER 4NIH 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6Gastrointestinal 2Breast 2Thoracic 1Sarcoma 1Lymphoid 1CNS 1

Conditions

Prostatic Neoplasms 3Urinary Bladder Neoplasms 2Wilms Tumor 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Neoplasms 1Medulloblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma 1Hodgkin Disease 1Brain Neoplasms 1

Interventions

Prednisone 122Docetaxel 118enzalutamide 101pembrolizumab 96Sunitinib 86Leuprolide 84Abiraterone Acetate 83Nivolumab 78Gemcitabine 76bicalutamide 54Radiotherapy 54Goserelin 54Bevacizumab 54Cisplatin 52Magnetic Resonance Spectroscopy 49Everolimus 49acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 46Sorafenib 40Carboplatin 40Paclitaxel 37Radiosurgery 36atezolizumab 35abiraterone 33pazopanib 32cabozantinib 32Ipilimumab 32Axitinib 30Cyclophosphamide 29Androgen Antagonists 29Radiation 28

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Has results × Genistein × Genitourinary × Clear all
NCT01489813 2025-02-05

Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment

Emory University

Phase 2 Completed
36 enrolled 7 charts
Genitourinary

Urinary Bladder Neoplasms

NCT02624388 2024-05-06

UVA-Gen001

University of Virginia

Phase 2 Terminated
4 enrolled 16 charts
CNSGenitourinaryLymphoidSarcoma

Brain Neoplasms, Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Neoplasms, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Neuroectodermal Tumors, Primitive

NCT02766478 2022-09-27

GeniPro

Emory University

Phase 2 Terminated
10 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

NCT00118040 2021-06-10

Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer

National Cancer Institute (NCI)

Phase 2 Completed
60 enrolled 24 charts
Genitourinary

Urinary Bladder Neoplasms

NCT01126879 2019-09-10

Genistein in Treating Patients With Prostate Cancer

Northwestern University

Phase 2 Terminated
12 enrolled 8 charts
Genitourinary

Prostatic Neoplasms

NCT01325311 2016-08-03

Cholecalciferol and Genistein Before Surgery in Treating Patients With Early Stage Prostate Cancer

National Cancer Institute (NCI)

Phase 2 Completed
15 enrolled 21 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡